MBX Biosciences (MBX) Stock: Buy, Sell, or Hold?
MBX - MBX Biosciences, Inc. Common Stock
$58.51
1.96 (3.47%)
▲
5d:
+9.1%
30d:
-3.91%
90d:
+1.4%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When MBX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MBX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MBX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MBX is currently trading at $58.51, which is considered slightly low relative to its 30-day fair value range of $57.70 to $64.46.
Technical Outlook: Technically, MBX is in a strong uptrend. Immediate support is located at $52.32, while resistance sits at $64.61. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $88.10 (+55.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MBX is in a strong uptrend. Immediate support is located at $52.32, while resistance sits at $64.61. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $88.10 (+55.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$57.70 -
$64.46
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading 55.8% below Wall St target ($88.10)
- NEUTRAL: Bottoming setup forming (54/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$57.70 -
$64.46
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$52.32
Resistance Level
$64.61
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.22
Wall Street Target
$88.10
(+55.8%)
Share & Embed Analysis
Last updated: October 02, 2026 4:19 PM ET
Data refreshes hourly during market hours. Next update: 5:19 PM
Data refreshes hourly during market hours. Next update: 5:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MBX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 76 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 56 HOLD |
